Shanghai Runda Med Tech Co Cash Flow Conversion Efficiency

Latest as of June 2023: 0.028x

Shanghai Runda Med Tech Co cash flow conversion efficiency. Based on the latest financial reports, Shanghai Runda Med Tech Co (603108) has a cash flow conversion efficiency ratio of 0.028x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥144.38 Million ≈ $21.13 Million USD) by net assets (CN¥5.15 Billion ≈ $752.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Runda Med Tech Co (2014–2024)

Cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024. This chart illustrates how Shanghai Runda Med Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shanghai Runda Med Tech Co stock quote for real-time trading data and today's change.

Shanghai Runda Med Tech Co Cash Flow Conversion Ratio Explained

Shanghai Runda Med Tech Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Runda Med Tech Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Runda Med Tech Co ranked by their cash flow conversion efficiency. Also see Shanghai Runda Med Tech Co (603108) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CureVac NV F:5CV	0.034x
Flotek Industries Inc NYSE:FTK	-0.051x
Neurones PA:NRO	0.144x
Montnets Cloud Technology Group Co Ltd SHE:002123	0.033x
Daily Journal Corp NASDAQ:DJCO	0.032x
LIFETECH SCI.DL-00000125 F:81X	N/A
CWB Automotive Electronics Co Ltd SHG:605005	0.056x
Cementos Pacasmayo SAA ADR NYSE:CPAC	0.141x

Annual Cash Flow Conversion Efficiency for Shanghai Runda Med Tech Co (2014–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Runda Med Tech Co from 2014 to 2024. Review free cash flow generation of Shanghai Runda Med Tech Co to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥5.60 Billion ≈ $820.06 Million	CN¥646.95 Million ≈ $94.67 Million	0.115x	-13.83%
2023-12-31	CN¥5.45 Billion ≈ $797.10 Million	CN¥729.72 Million ≈ $106.78 Million	0.134x	+256.49%
2022-12-31	CN¥5.01 Billion ≈ $733.10 Million	CN¥-428.86 Million ≈ $-62.76 Million	-0.086x	-201.31%
2021-12-31	CN¥4.39 Billion ≈ $642.69 Million	CN¥371.11 Million ≈ $54.31 Million	0.084x	+6.59%
2020-12-31	CN¥4.08 Billion ≈ $597.07 Million	CN¥323.44 Million ≈ $47.33 Million	0.079x	+13.00%
2019-12-31	CN¥3.52 Billion ≈ $514.56 Million	CN¥246.68 Million ≈ $36.10 Million	0.070x	-59.24%
2018-12-31	CN¥3.13 Billion ≈ $458.14 Million	CN¥538.90 Million ≈ $78.86 Million	0.172x	+638.52%
2017-12-31	CN¥2.75 Billion ≈ $402.20 Million	CN¥-87.85 Million ≈ $-12.86 Million	-0.032x	+43.39%
2016-12-31	CN¥2.22 Billion ≈ $325.17 Million	CN¥-125.47 Million ≈ $-18.36 Million	-0.056x	+76.87%
2015-12-31	CN¥928.55 Million ≈ $135.88 Million	CN¥-226.69 Million ≈ $-33.17 Million	-0.244x	-421.52%
2014-12-31	CN¥475.63 Million ≈ $69.60 Million	CN¥36.11 Million ≈ $5.28 Million	0.076x	--

About Shanghai Runda Med Tech Co

SHG:603108 China Diagnostics & Research

Market Cap

$885.13 Million

CN¥6.05 Billion CNY

Market Cap Rank

#9121 Global

#2219 in China

Share Price

CN¥10.02

Change (1 day)

-2.62%

52-Week Range

CN¥8.83 - CN¥20.04

All Time High

CN¥26.34